{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:04:33Z","timestamp":1794456273561,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cyto.2022.155862","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T15:16:16Z","timestamp":1647530176000},"page":"155862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Group 3 innate lymphocytes (ILC3s) upregulate IL-22 in response to elevated intracellular cAMP levels"],"prefix":"10.1016","volume":"153","author":[{"given":"Prakash","family":"Sah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan T.","family":"Derouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine L.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Zenewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6237","key":"10.1016\/j.cyto.2022.155862_b0005","doi-asserted-by":"crossref","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cyto.2022.155862_b0010","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3389\/fimmu.2019.00861","article-title":"Innate Lymphoid Cells in Mucosal Immunity","volume":"10","author":"Panda","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2022.155862_b0015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate Lymphoid Cells: 10 Years On","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cyto.2022.155862_b0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41422-020-0323-8","article-title":"Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity","volume":"30","author":"Klose","year":"2020","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.cyto.2022.155862_b0025","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192195","article-title":"The role of IL-22 in intestinal health and disease","volume":"217","author":"Keir","year":"2020","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.cyto.2022.155862_b0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/35080089","article-title":"The bacterial toxin toolkit","volume":"2","author":"Schiavo","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155862_b0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-micro-091014-104523","article-title":"Anthrax Pathogenesis","volume":"69","author":"Moayeri","year":"2015","journal-title":"Annu. Rev. Microbiol."},{"issue":"10","key":"10.1016\/j.cyto.2022.155862_b0040","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.cyto.2022.155862_b0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/toxins8030069","article-title":"The Ins and Outs of Anthrax Toxin","volume":"8","author":"Friebe","year":"2016","journal-title":"Toxins (Basel)"},{"issue":"7","key":"10.1016\/j.cyto.2022.155862_b0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/toxins4070505","article-title":"Bacillus anthracis edema factor substrate specificity: evidence for new modes of action","volume":"4","author":"Gottle","year":"2012","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/j.cyto.2022.155862_b0055","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/toxins3060660","article-title":"T cell targeting by anthrax toxins: two faces of the same coin","volume":"3","author":"Paccani","year":"2011","journal-title":"Toxins (Basel)"},{"issue":"10","key":"10.1016\/j.cyto.2022.155862_b0060","doi-asserted-by":"crossref","first-page":"e1006690","DOI":"10.1371\/journal.ppat.1006690","article-title":"Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling","volume":"13","author":"Seshadri","year":"2017","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.cyto.2022.155862_b0065","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jaci.2010.12.1104","article-title":"The adenylate cyclase toxin of Bacillus anthracis is a potent promoter of T(H)17 cell development","volume":"127","author":"Rossi Paccani","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2022.155862_b0070","doi-asserted-by":"crossref","first-page":"e1000325","DOI":"10.1371\/journal.ppat.1000325","article-title":"The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling","volume":"5","author":"Rossi Paccani","year":"2009","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.cyto.2022.155862_b0075","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20082293","article-title":"Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling","volume":"206","author":"Boniface","year":"2009","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cyto.2022.155862_b0080","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/art.1780370623","article-title":"Modulation of helper T cell function by prostaglandins","volume":"37","author":"Gold","year":"1994","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2022.155862_b0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1101029","article-title":"Regulation of immune responses by prostaglandin E2","volume":"188","author":"Kalinski","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155862_b0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2017.04.045","article-title":"Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis","volume":"141","author":"Robb","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2022.155862_b0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/mi.2014.71","article-title":"An in vitro model of innate lymphoid cell function and differentiation","volume":"8","author":"Allan","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2022.155862_b0100","first-page":"201","article-title":"Forskolin: a unique diterpene activator of cyclic AMP-generating systems","volume":"7","author":"Seamon","year":"1981","journal-title":"J. Cyclic Nucleotide Res."},{"key":"10.1016\/j.cyto.2022.155862_b0105","doi-asserted-by":"crossref","unstructured":"P. Sassone-Corsi, The cyclic AMP pathway, Cold Spring Harb Perspect Biol 4(12) (2012).","DOI":"10.1101\/cshperspect.a011148"},{"issue":"3","key":"10.1016\/j.cyto.2022.155862_b0110","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.176.3.1776","article-title":"Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens","volume":"176","author":"Duverger","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2022.155862_b0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.1999.tb01248.x","article-title":"Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice","volume":"23","author":"Hormozi","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"6","key":"10.1016\/j.cyto.2022.155862_b0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.vaccine.2005.08.065","article-title":"Evidence for adjuvanticity of anthrax edema toxin","volume":"24","author":"Quesnel-Hellmann","year":"2006","journal-title":"Vaccine"},{"issue":"6279","key":"10.1016\/j.cyto.2022.155862_b0125","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1126\/science.aad9903","article-title":"Prostaglandin E(2) constrains systemic inflammation through an innate lymphoid cell-IL-22 axis","volume":"351","author":"Duffin","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.cyto.2022.155862_b0130","doi-asserted-by":"crossref","first-page":"e1004644","DOI":"10.1371\/journal.ppat.1004644","article-title":"Bacterial immune evasion through manipulation of host inhibitory immune signaling","volume":"11","author":"Van Avondt","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cyto.2022.155862_b0135","doi-asserted-by":"crossref","first-page":"23346","DOI":"10.1038\/srep23346","article-title":"In vivo dynamics of active edema and lethal factors during anthrax","volume":"6","author":"Rougeaux","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:45:00Z","timestamp":1760910300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466622000710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":27,"alternative-id":["S1043466622000710"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155862","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Group 3 innate lymphocytes (ILC3s) upregulate IL-22 in response to elevated intracellular cAMP levels","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155862"}}